Early Data Promising for Cryospray COPD Treatment
A 12-month feasibility study of the RejuvenAir Metered Cryospray system revealed "clinically meaningful improvements" in COPD patients with chronic bronchitis.
A 12-month feasibility study of the RejuvenAir Metered Cryospray system revealed "clinically meaningful improvements" in COPD patients with chronic bronchitis.